SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Sotera Health Company (Nasdaq – SHC)

BALA CYNWYD – April 1, 2024 /NewsFile/ – Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Sotera Health Company (“Sotera” or the “Company”) (Nasdaq – SHC) for possible breaches of fiduciary duty and other violations of federal and state law. The investigation concerns possible corporate misconduct detailed in a recently filed amended securities fraud complaint against Sotera related to the disposal of waste substances in excess of the Environmental Protection Agency’s standards and regulations.

The investigation seeks to determine whether members of the Sotera board of directors violated the securities laws and/or breached their fiduciary duties in connection with the allegations leveled in the amended complaint. If you have owned shares of Sotera stock since prior to September 19, 2022, and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman by email at, or call toll free 855-576-4847.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.